Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Tucson, AZ
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Denver, CO
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Bridgeport, CT
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Melbourne, FL
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Melbourne, FL
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Ormond Beach, FL
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Maywood, IL
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Iowa City, IA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Owensboro, KY
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Boston, MA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Lincoln, NE
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Bronx, NY
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Lancaster, PA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Germantown, TN
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Roanoke, VA
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Beloit, WI
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Madison, WI
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated:  1/8/2016
University of California at San Francisco
mi
from
San Francisco, CA
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated: 1/8/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated:  1/8/2016
University of Maryland Medical Center
mi
from
Baltimore, MD
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated: 1/8/2016
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated:  1/8/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated: 1/8/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated:  1/8/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated: 1/8/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated:  1/8/2016
Cornell University
mi
from
New York, NY
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Status: Enrolling
Updated: 1/8/2016
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis Patients
Status: Enrolling
Updated:  1/11/2016
Winthrop University Hospital
mi
from
Mineola, NY
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis Patients
Status: Enrolling
Updated: 1/11/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
The Optiflow Patency and Maturation Study
The "OPEN" Study Optiflow PatEncy and MaturatioN
Status: Enrolling
Updated:  1/11/2016
University of Cincinnati - Division of Nephrology
mi
from
Cincinnati, OH
The Optiflow Patency and Maturation Study
The "OPEN" Study Optiflow PatEncy and MaturatioN
Status: Enrolling
Updated: 1/11/2016
University of Cincinnati - Division of Nephrology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Acute Renal Failure Post Liver Transplantation
Acute Renal Failure Post Liver Transplantation: The Role of Cytokines and Oxidative Stress
Status: Enrolling
Updated:  1/12/2016
Annette C. and Harold C. Simmons Tranplant Institute at Baylor Medical Center Dallas
mi
from
Dallas, TX
Acute Renal Failure Post Liver Transplantation
Acute Renal Failure Post Liver Transplantation: The Role of Cytokines and Oxidative Stress
Status: Enrolling
Updated: 1/12/2016
Annette C. and Harold C. Simmons Tranplant Institute at Baylor Medical Center Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Stratton VA Medical Center
mi
from
Albany, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Stratton VA Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Clifton Park, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Clifton Park, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Saratoga Springs, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated:  1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Troy, NY
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Status: Enrolling
Updated: 1/13/2016
Hortense and Louis Rubin Dialysis Center
mi
from
Troy, NY
Click here to add this to my saved trials
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
A Randomized Study on the Effects of Sevelamer Carbonate Versus Calcium Acetate on Biomarkers of Vascular Calcification, Inflammation, and Endothelial Dysfunction in Chronic Kidney Disease Stages 3 and 4
Status: Enrolling
Updated:  1/13/2016
Albany Medical Center South Clinical Campus
mi
from
Albany, NY
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
A Randomized Study on the Effects of Sevelamer Carbonate Versus Calcium Acetate on Biomarkers of Vascular Calcification, Inflammation, and Endothelial Dysfunction in Chronic Kidney Disease Stages 3 and 4
Status: Enrolling
Updated: 1/13/2016
Albany Medical Center South Clinical Campus
mi
from
Albany, NY
Click here to add this to my saved trials
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
Status: Enrolling
Updated:  1/13/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
Status: Enrolling
Updated: 1/13/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3)
Status: Enrolling
Updated:  1/13/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3)
Status: Enrolling
Updated: 1/13/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Risk of Chronic Kidney Disease Progression
Risk of Chronic Kidney Disease Progression
Status: Enrolling
Updated:  1/18/2016
Winthrop University Hospital
mi
from
Mineola, NY
Risk of Chronic Kidney Disease Progression
Risk of Chronic Kidney Disease Progression
Status: Enrolling
Updated: 1/18/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
A Phase I, Single Center Trial of Adoptive Immunotherapy With T-reg Adoptive Cell Transfer (TRACT) to Prevent Rejection in Living Donor Kidney Transplant Recipients
Status: Enrolling
Updated:  1/19/2016
Northwestern University-Comprehensive Transplant Center
mi
from
Chicago, IL
Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
A Phase I, Single Center Trial of Adoptive Immunotherapy With T-reg Adoptive Cell Transfer (TRACT) to Prevent Rejection in Living Donor Kidney Transplant Recipients
Status: Enrolling
Updated: 1/19/2016
Northwestern University-Comprehensive Transplant Center
mi
from
Chicago, IL
Click here to add this to my saved trials
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease
Status: Enrolling
Updated:  1/20/2016
Duke University Medical Center Dialysis Unit
mi
from
Durham, NC
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease
Status: Enrolling
Updated: 1/20/2016
Duke University Medical Center Dialysis Unit
mi
from
Durham, NC
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Denver, CO
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Detroit, MI
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Tempe, AZ
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Meridian, ID
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Orangeburg, SC
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
San Antonio, TX
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials